FREENOME PRESENTS A SUBJECT POPULATION ANALYSIS OF A CLINICAL STUDY USING A MULTIOMICS BLOOD TEST FOR THE EARLY DETECTION OF COLORECTAL CANCER

– PREEMPT CRC is a large, representative registrational study for the early detection of colorectal cancer – Findings presented at the Western Colorectal Cancer Consortium Conference SOUTH SAN FRANCISCO, Calif., March 6, 2023 /PRNewswire/ -- Today Freenome, a privately held biotech...

Click to view original post